Q3 2024 EPS Estimates for DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Reduced by Leerink Partnrs

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Equities researchers at Leerink Partnrs reduced their Q3 2024 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a note issued to investors on Tuesday, July 9th. Leerink Partnrs analyst M. Cherny now expects that the medical instruments supplier will earn $0.52 per share for the quarter, down from their prior estimate of $0.57. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $2.02 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA’s FY2025 earnings at $2.37 EPS and FY2027 earnings at $3.06 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, meeting the consensus estimate of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. During the same quarter last year, the business earned $0.39 earnings per share. DENTSPLY SIRONA’s revenue was down 2.6% compared to the same quarter last year.

Several other research firms have also recently commented on XRAY. Evercore ISI lowered their target price on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday. Barrington Research reiterated an “outperform” rating and set a $38.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, July 8th. Robert W. Baird cut their target price on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a research report on Friday, May 3rd. Needham & Company LLC lowered their price target on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating on the stock in a research report on Friday, May 3rd. Finally, StockNews.com downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Moderate Buy” and an average target price of $34.33.

DENTSPLY SIRONA Stock Down 0.7 %

Shares of DENTSPLY SIRONA stock opened at $25.53 on Thursday. DENTSPLY SIRONA has a 1-year low of $23.94 and a 1-year high of $41.65. The business’s fifty day moving average price is $26.66 and its two-hundred day moving average price is $31.06. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.97. The company has a market capitalization of $5.30 billion, a P/E ratio of -58.02, a PEG ratio of 1.09 and a beta of 1.01.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in XRAY. Principal Securities Inc. acquired a new position in shares of DENTSPLY SIRONA in the fourth quarter worth $26,000. VisionPoint Advisory Group LLC lifted its holdings in shares of DENTSPLY SIRONA by 104.2% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock valued at $26,000 after buying an additional 395 shares during the last quarter. Headlands Technologies LLC bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $30,000. Parkside Financial Bank & Trust increased its holdings in DENTSPLY SIRONA by 33.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after buying an additional 292 shares during the last quarter. Finally, Anchor Investment Management LLC bought a new position in DENTSPLY SIRONA during the fourth quarter valued at approximately $47,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 3,577 shares of the stock in a transaction dated Friday, May 31st. The shares were acquired at an average price of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the acquisition, the director now owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, July 12th. Shareholders of record on Friday, June 28th were paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 2.51%. The ex-dividend date of this dividend was Friday, June 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -145.45%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.